|
|
|
Clinical Research Detail |
|
|
|
Title Of Study |
A Multicenter, Open Label, Comparative Study to Evaluate the Immunogenicity and Reactogenicity of a New Fully Liquid Hexavalent DTwP-Hepb-Hib-IPV Vaccine (EasysixTM, Panacea Biotec Ltd.) in Healthy Infants.
|
|
|
Disease Condition |
Primary immunization of infants for the prevention of Diphtheria, Pertussis, Tetanus, H. Influenzae, Hepatitis B and Poliomyelitis.
|
|
|
Phase of Trial |
Phase-2 & 3
|
Discipline |
Paediatrics - Medicine
|
|
|
Start date of Trial |
2/28/2011
|
Closing Date of Trial |
2/28/2012
|
|
|
|